Introduction and Objective: There are more than 101 million individuals living with diabetes in India.Meeting treatment goals for HbA1c, Blood pressure and Cholesterol(ABC) can help prevent diabetes complications.We assessed diabetes awareness, management gaps and attainment of ABC goals among rural South Indian with self-reported diabetes.Methods: The Telemedicine pRoject for screENing Diabetes and its complications in […]
Read MoreAuthor: sugaradmin
Noninvasive Procedure Helped This Mother-Daughter Duo Lose 163 Pounds
Share on PinterestMolly Madore (left) and her mother, Diane Madore, underwent the same noninvasive weight loss procedure, losing a combined 163 pounds. Design by Healthline / Photo Courtesy of Diane and Molly A mother and daughter teamed up to undergo the same noninvasive weight loss procedure after years of difficulty with weight management. After Molly […]
Read More3061-LB: Combination Treatment of Oral Small Molecule GLP-1 Receptor Agonist Aleniglipron and Small Molecule Amylin Receptor Agonist ACCG-2671 Demonstrated Additional Weight Loss than Monotreatment in Obese NHPs
Introduction and Objective: GLP-1 receptor activation and amylin receptor activation are two complementary mechanisms of action for obesity treatments. Combination therapy of long-acting peptides semaglutide and cagrilintide have demonstrated enhanced efficacy over single agents for obesity treatment in clinical trials. Small molecules offer potential advantages over peptides, including scalability, room temperature shipping and storage, and […]
Read More1763-P: Impact of Short-Term Intensive De-escalation Therapy on Long-Term Regimen Simplification in Poorly Controlled Type 2 Diabetes: A National Multicenter, Prospective, Randomized Trial
Introduction and Objective: To explore whether short-term intensive glucose control can minimize the escalation of treatment in poorly controlled type 2 diabetes.Methods: Patients with poorly controlled type 2 diabetes despite receiving two or more hypoglycemic agents were randomly assigned to three intensive glucose control groups, with a 36-week core period followed by a 24-week extension. […]
Read More2335-P: Metabolomic Analysis Reveals That Prediabetes Subgroups Have Different Likelihoods of T2D Onset: A Definition, Etiology, and Function: Integration to Enhance T2D Treatment (DEFINE-T2D) Consortium Analysis
Introduction and Objective: Patients with T2D can be clustered into distinct etiologic subgroups, but it is not clear if the same is true for those with prediabetes (preDM). As metabolites mark the onset of T2D prior to clinical thresholds, we clustered individuals with preDM by preDM-related metabolites and examined subgroups for long-term T2D risk.Methods: Data […]
Read More2126-P: Glycemia Risk Index to Characterize Pediatric Type 1 Diabetes Population
Introduction and Objective: T1D population health requires synthesizing multiple data points. GRI summarizes severity-weighted hypo/hyperglycemia into zone categories. We assessed whether GRI can be used to characterize a pediatric cohort in relation to CGM targets.Methods: We analyzed up to 24 months of CGM data in 225 children with T1D and calculated GRI in consecutive 14-day […]
Read More2384-P: Mortality in a Contemporary Type 1 Diabetes Cohort: The CACTI Study
Introduction and Objective: All-cause mortality has been on the decline among people with type 1 diabetes (T1D). Despite this trend, excess mortality remains high among people with T1D compared to those without T1D. We examined the all-cause and cause-specific mortality in a contemporary T1D cohort and explored factors that influenced mortality.Methods: Participants in the Coronary […]
Read More1987-P: Real-World Gains Evident for Eye Exams for Diabetes in Rural and Urban Clinics with Use of Autonomous AI
Introduction and Objective: Annual eye examinations for diabetes (EEDs) are essential for early detection of diabetic retinopathy, yet adherence remains suboptimal, particularly in rural communities where access to eye care is limited. Autonomous AI systems offer a scalable approach to expand patient access at the point of care. We evaluated the real-world impact of LumineticsCoreâ„¢, […]
Read More2139-P: Whey Protein Preload Reduces Postprandial Glucose Excursions in Pregnancy: Results from a Randomized Pilot Study
Introduction and Objective: Rapid postprandial glucose rises during pregnancy may adversely affect offspring health, while practical dietary advice for gestational diabetes remains limited. In type 2 diabetes, premeal whey protein (WP) reduces postprandial blood glucose. We investigated whether preprandial WP attenuates glucose excursions after carbohydrate intake in pregnant women and explored underlying mechanisms.Methods: In this […]
Read More1112-OR: Intersectional Viral Mapping Reveals a Functional PVH MC4R -> PBN MC4R Neurocircuit for Glycemic Control
Introduction and Objective: PVHMC4R and PBNMC4R neurons are central to the regulation of energy intake and glucose metabolism, yet the neurocircuit mechanisms underlying glycemic control at these neural nodes remain unclear. Here, we investigated whether a PVHMC4R → PBNMC4R neurocircuit contributes to glucoregulation using an intersectional viral mapping approach.Methods: To anatomically define this pathway, we […]
Read More